Rickettsia lanei Rickettsiosis, Oregon, USA, 2025

https://wwwnc.cdc.gov/eid/article/32/4/25-1962_article

Strongyloides Genetic Diversity among Humans, Dogs, and Nonhuman Primates, Central African Republic, 2016–2022

https://wwwnc.cdc.gov/eid/article/32/3/25-0526_article

[Comment] Preventing tuberculosis in advanced HIV disease
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00277-2/fulltext?rss=yes

The persistent and high burden of advanced HIV disease in endemic settings is a major threat to global efforts to reduce AIDS-related hospitalisations and deaths. In 2024, over 600 000 people died from AIDS-related opportunistic infections, with over half of these deaths due to cryptococcal meningitis and tuberculosis. We now have innovative diagnostic, preventive, and therapeutic interventions to combat these diseases, but implementing these new tools among people with advanced HIV presents several enduring challenges.

[Articles] Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00246-2/fulltext?rss=yes

1HP initiation before hospital discharge was non-inferior to outpatient initiation among adults with AHD and cryptococcosis. These data suggest that following exclusion of active tuberculosis disease, inpatient 1HP initiation is feasible and comparably safe compared with outpatient initiation.

Environmental and Phylogenetic Investigations of Aspergillus flavus Outbreak Linked to Contaminated Building Materials, Denmark, 2025

https://wwwnc.cdc.gov/eid/article/32/3/25-1219_article

Rapid Interventions to Limit Outbreak of Invasive Streptococcus pneumoniae in Correctional Facility, North Carolina, USA, 2024

https://wwwnc.cdc.gov/eid/article/32/3/25-0789_article

Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020–2024

https://wwwnc.cdc.gov/eid/article/32/3/25-1893_article

Seroincidence Rate of Typhoidal Salmonella in Children, Kenya, 2017–2018

https://wwwnc.cdc.gov/eid/article/32/3/25-0469_article

Oestrus ovis Nasal Myiasis with Pupation in Human Host, Greece, October 2025

https://wwwnc.cdc.gov/eid/article/32/3/25-1077_article

lsaC and Tandem lsaE-lnuB Resistance Genes in Invasive Group A Streptococcus

https://wwwnc.cdc.gov/eid/article/32/3/25-1776_article

Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia

https://wwwnc.cdc.gov/eid/article/32/3/25-1350_article

Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan

https://wwwnc.cdc.gov/eid/article/32/3/25-1418_article

Two Cases of Posttraumatic Kosakonia Infection, Argentina, 2023

https://wwwnc.cdc.gov/eid/article/32/3/25-1714_article

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group

https://wwwnc.cdc.gov/eid/article/32/3/25-1165_article

Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023

https://wwwnc.cdc.gov/eid/article/32/3/25-1459_article

Extraintestinal Entamoeba moshkovskii Infection, Eastern India

https://wwwnc.cdc.gov/eid/article/32/3/25-1065_article

CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo

https://wwwnc.cdc.gov/eid/article/32/3/25-1171_article

Mycobacterium nanjing sp. nov. Isolated from Cutaneous Infection, China

https://wwwnc.cdc.gov/eid/article/32/3/25-2001_article

Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe

https://wwwnc.cdc.gov/eid/article/32/3/25-1775_article

Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA

https://wwwnc.cdc.gov/eid/article/32/3/25-1042_article

Dracunculiasis, 1674

https://academic.oup.com/cid/article/82/3/i/8525105?rss=1